PhaseBio Pharmaceuticals, Inc. (PHASQ)

PhaseBio Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2021	2020	2019	2018	2017
Market Capitalization	0	77	98	168	16	56
Market Cap Growth	-83.47%	-21.41%	-41.88%	924.76%	-70.86%	-9.21%
Enterprise Value	-2	43	82	109	-37	58
PE Ratio	-	-585.39	-0.99	-4.28	-0.69	-5.49
PS Ratio	0.00	7084.11	305.09	71.15	24.54	-
PB Ratio	-0.25	-0.82	-3.87	2.80	0.32	-0.58
P/FCF Ratio	-0.48	-1.53	-1.59	-4.14	-0.95	-6.64
P/OCF Ratio	-0.50	-1.62	-1.63	-4.24	-0.96	-6.81
EV/Sales Ratio	33.10	3949.13	255.11	46.02	-55.60	-
EV/EBITDA Ratio	0.96	25.73	-0.84	-2.86	1.87	-7.85
EV/EBIT Ratio	1.03	-327.97	-0.84	-2.85	1.86	-7.75
EV/FCF Ratio	-0.44	-0.85	-1.33	-2.68	2.16	-6.88
Debt / Equity Ratio	-0.05	-0.08	-0.48	0.25	0.15	-0.03
Debt / EBITDA Ratio	0.19	4.72	-0.13	-0.39	-0.38	-2.08
Debt / FCF Ratio	-0.09	-0.16	-0.20	-0.36	-0.44	-1.83
Quick Ratio	0.32	1.50	1.88	8.88	13.39	0.76
Current Ratio	0.47	1.75	2.68	9.30	13.68	0.78
Asset Turnover	0.02	0.00	0.01	0.03	0.01	0
Interest Coverage	-142.66	137.72	-58.72	-36.93	-5.01	-3.14
Return on Equity (ROE)	-23.71%	0.14%	391.10%	-65.44%	-46.82%	10.52%
Return on Assets (ROA)	125.58%	-0.22%	-195.73%	-47.58%	-37.84%	-72.68%
Return on Capital (ROIC)	-30.61%	0.15%	649.04%	-53.21%	-33.62%	10.42%
Earnings Yield	55671858.00%	-0.17%	-100.96%	-23.36%	-145.47%	-18.21%
FCF Yield	-123644000.00%	-65.29%	-62.86%	-24.14%	-104.75%	-15.07%
Buyback Yield / Dilution	-2.49%	-1.18%	-5.68%	-418.25%	52.85%	9.21%
Total Shareholder Return	-2.49%	-1.18%	-5.68%	-418.25%	52.85%	9.21%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.